𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer

✍ Scribed by José Baselga


Book ID
119597771
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
202 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES